Patient Financial News

Cyclone Michaung and the rain-related activities took lives of at least 17 people in the southern part of India. Incessant heavy rainfall has caused flood-liker situations in several parts of Tamil Nadu, especially capital city Chennai. The situation has stranded many, causing mobile connection, and internet outage, flooded homes.

Health Ministry Tuesday ordered an inquiry into ‘cash-for-kidney racket’ allegations against Indraprastha Medical Corporation Ltd, a unit of the Apollo Hospitals group, news agency PTI reported citing sources. Earlier on Monday, the Indraprastha Medical Corporation Ltd (IMCL) rejected the allegations of ‘cash for kidney racket’ asserting that the hospital follows every legal and ethical requirement for transplants, including government guidelines.

By David Carnevali

Kyle McCord, Ohio State's promising quarterback, has entered the transfer portal, leaving the Buckeyes searching for their next signal-caller. McCord, a five-star recruit from St. Joseph's Prep in Philadelphia, had patiently bided his time before earning the starting role this year. With his departure, the spotlight now falls on potential successors, and the upcoming Cotton Bowl against Missouri may serve as a platform for one quarterback to stake their claim for the 2024 season.

IMCL) on Monday asserted that it follows every legal and ethical requirement for transplants, including government guidelines, refuting a report which alleged that it was involved in 'cash for kidney racket'. The hospital, a part of the Apollo Hospitals group, said each foreign donor is required to provide a certification from their respective foreign governments that the donor and recipient are indeed related before undertaking transplant.

Biotechnology giant Roche (OTC:RHHBY)) will acquire obesity drug maker Carmot Therapeutics in a $3.1 billion deal, it was announced Monday.

Pfizer shares sank Friday when the drugmaker announced that it was abandoning a twice-daily obesity treatment after more than half the patients in a clinical trial stopped taking it

By Ludwig Burger and Noele Illien

Stocks were down yesterday, but a $6.5 billion buy imbalance sent S&P 500 screaming higher into the close. Yesterday was month end, which can create large buy or sell imbalances. Generally speaking, the quarter ends generate enormous imbalances, but yesterday’s was almost equal to larger, driving the market higher in the final 30 minutes of trading.

By Rohit Mundra

George Putnam III says most brokers and Wall Street analysts avoid turnaround situations because they have been burned by the stock on the way down. According to Putnam, most investors chase the same stocks which are followed by hundreds of highly trained analysts and so it is hard to outperform. So he advises investors to seek out unloved, down-and-out turnaround situations as when these stocks eventually do come back, they can soar as investors pile into them. «Our approach is simple. We avoid the „blue chips“ and „hot“ stocks that most investors are stampeding into. Instead, we search out companies that have had some problems and are temporarily out-of-favor, but are in the process of turning around. These stocks seem like laggards when we first identify them, but as the turnaround becomes more evident, Wall Street will jump into the stock and push the price up — often dramatically,» he wrote in his Turnaround Investment Letter. Who is George Putnam III?

flights and long-distance trains out of Munich, with Christmas markets closed, some ski lifts unable to run and a football match called off as the city battled with the icy conditions. Flights were not scheduled to depart or arrive at Munich airport until at least 6 a.m. (0500 GMT) on Sunday according to a statement on its website.

corrode metals and gunk up infrastructure. Despite the scale of the problem, it has drawn little attention. One reason is that biofilms are comparatively poorly understood.

Jasmeen Kaur, who runs a boutique in Delhi's Tilak Nagar. Around Diwali, she was promoting salwar suits on Instagram Live, when she unselfconsciously uttered the now-famous words, 'So beautiful, so elegant, just looking like a wow!' The keyword here is 'unselfconsciously'. Since then, the sentence has trended like a monster.

Malhotra has alleged that the World Health Organisation (WHO) has completely lost its independence and suggested that the Indian government should ignore its advice on various issues and exit the global health body. Talking to PTI, Malhotra, who gave a lecture at the All India Institute of Medical Sciences (AIIMS) here on «The Corporate Capture of Medicine and Public Health» recently, also claimed that regulators do not independently evaluate data related to drugs. «Drug regulators, such as the FDA, who are supposed to evaluate drugs, receive 65 per cent of their funding from big pharma.

credit cards have become essential in daily life, offering convenience and flexible repayment options, allowing them to take greater control of their finances. They offer benefits like one-time signing bonus, cashback, rewards points, and frequent-flyer miles. Judicious use of cards offering these benefits can help maintain a healthy credit score, which is necessary to avail of other financial services.

Investing.com -- Shares in Pfizer (NYSE:PFE) slumped in early trading on Friday after the drugmaker said that the twice-daily form of its new oral obesity treatment will not advance into late-stage studies.

Explore Wall Street's expert insights with this ProResearch article, which will exclusively be available to InvestingPro subscribers soon. Enhance your investment strategy with ProPicks, our newest product featuring strategies that have outperformed the S&P 500 by up to 700%. This Cyber Monday, enjoy up to 60% off, plus an extra 10% off a 2-year subscription with the code research23 , reserved for the first 500 quick subscribers. To ensure ongoing access to valuable content like this, step up your investment game with InvestingPro.

We don’t support this browser anymore. This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Zydus Lifesciences Ltd on Friday said it has received final approval from the US health regulator for its generic version of Ivabradine tablets indicated for the treatment of heart failure. The approval by the US Food and Drug Administration (USFDA) is for Ivabradine tablets of strengths 5 mg and 7.5 mg, the company said in a regulatory filing.

Charlie Munger didn't manage to help pull off one final deal with his lifelong partner Warren Buffett, but he remained hopeful that Berkshire Hathaway, with nearly $160 billion cash, will find its elephant one day.